Bitcoin held above $80,000 on November 5 after rising sharply on Wednesday, while Injective’s INJ token rallied as Canary’s staked INJ exchange-traded fund began trading on Nasdaq. CoinDesk reported the Bitcoin move, and The Defiant reported the ETF listing. The two moves are connected by a broader return of interest in tokens beyond Bitcoin.
But they are not the same trade. Bitcoin remains the market’s largest crypto asset, while INJ is reacting to a new regulated product built around its own token.
Bitcoin stays above a key level
Holding above $80,000 matters because that price has become an easy line for traders to watch after Wednesday’s jump. A price level does not guarantee the next move, but staying above it suggests buyers have so far absorbed selling pressure that might have pushed Bitcoin back below the mark.
CoinDesk’s report describes Bitcoin holding that level rather than extending the story into a new surge. That distinction matters. A sharp move can bring in fast traders, while a period of holding above a round number can test whether demand is still there after the initial rush.
Bitcoin’s move also set the tone for the wider crypto market. When the largest asset stabilizes after a gain, traders often become more willing to look at smaller tokens. That does not mean every altcoin, meaning a crypto asset other than Bitcoin, will rise for the same reason.
Canary’s fund gives INJ a new route to market
Canary’s staked INJ ETF began trading on Nasdaq, The Defiant reported. An ETF is a fund that trades on a stock exchange, so investors can buy and sell shares of it through a regular brokerage account rather than directly handling the token themselves. The word “staked” is important here.
Staking generally means committing tokens to help support a blockchain network in return for rewards. A staked INJ ETF is therefore designed around exposure to INJ while incorporating that staking activity, rather than simply holding a token in a passive wrapper. That structure can matter for investors who want regulated market access.
It may also matter for INJ because an ETF creates another channel through which attention and capital can reach the asset. Still, the start of trading does not by itself establish how much investor demand the fund will attract.
INJ joins a broader altcoin rebound
CryptoNews reported that INJ, PEARL and Zcash’s ZEC rose as traders returned to altcoins. The report places Injective’s move inside a wider shift in trading interest, rather than treating the ETF listing as the only reason for its gain. That broader backdrop is worth keeping in view.
A token can rise on a specific catalyst, such as a Nasdaq-listed fund, while also benefiting from traders taking more risk across the market. If interest in altcoins fades, a listing alone may not be enough to keep the same momentum going. Coinpedia’s coverage asked whether INJ could reach $60 after ETF approval.
That is a price question, not a confirmed outcome. The useful near-term facts are more concrete: the fund has begun trading, Bitcoin remains above $80,000, and traders are again moving into assets beyond Bitcoin. The next clear level for the broader market is Bitcoin’s $80,000 mark.
For INJ, the practical test is whether interest in Canary’s Nasdaq-listed staked ETF continues after its first days of trading.